Company Overview of Tekla Life Sciences Investors
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of b...
2 Liberty Square
Boston, MA 02109
Founded in 1992
Key Executives for Tekla Life Sciences Investors
Principal Executive Officer, President, Trustee and Member of Valuation Committee
Principal Financial Officer, Chief Compliance Officer, Secretary and Treasurer
Compensation as of Fiscal Year 2016.
Tekla Life Sciences Investors Key Developments
Tekla Life Sciences Investors, Annual General Meeting, Jun 14, 2016
Apr 18 16
Tekla Life Sciences Investors, Annual General Meeting, Jun 14, 2016, at 10:00 US Eastern Standard Time. Location: 100 Federal Street, 19th Floor Boston, MA 02110 United States Agenda: To consider the election of trustees of fund; to consider the ratification or rejection of the selection of Deloitte & Touche LLP as the independent registered public accountants of fund for the fiscal year ending September 30, 2016; to consider change the subclassification of the company from ‘diversified’ to ‘non-diversified; and eliminate the related fundamental investment restriction; to amend the company’s fundamental investment restriction regarding issuing senior securities; to remove the company's fundamental investment restriction regarding investments in other investment companies; and to consider the transaction of such other business as may properly come before the annual meeting and any adjournment(s) or postponement(s) thereof.
Tekla Life Sciences Investors Declares Quarterly Dividend, Payable on June 10, 2016
Apr 14 16
Tekla Life Sciences Investors has declared a quarterly dividend of $0.37 per share, a 23% decline from its prior dividend of $0.48, and a 31% drop from its $0.54 dividend from the same quarter last year. The dividend for the management investment fund is payable on June 10 to shareholders of record as of April 25.
Tekla Life Sciences Investors Declares Special Cash Distribution, Payable on January 8, 2016
Dec 18 15
On December 18, 2015, Tekla Life Sciences Investors declared a special cash distribution of $0.71 per share in order to satisfy annual tax distribution requirements. The record date for the distribution is December 30, 2015 and the payable date is January 8, 2016. The Fund will trade ex-distribution on December 28, 2015.
Similar Private Companies By Industry
Recent Private Companies Transactions